LEADERSHIP & GOVERNANCE
Experience Across Markets, Industries, and Two Economies.
JP3E’s leadership and Board support disciplined execution across public markets, strategic assets, life sciences, institutional finance, and U.S.–Korea business development.
Portrait spaces are reserved for the final executive photography currently in production.
- JKPPORTRAIT RESERVED01
John K. Park
Chairman & Chief Executive Officer
Corporate strategy · Strategic industries · Commercial execution
John K. Park leads JP3E Holdings and serves as the company’s principal executive for its public-company and strategic-platform initiatives. JP3E’s public announcements identify him as the operating lead for strategic-materials execution and company development.
- HJPORTRAIT RESERVED02
Henry Ji, Ph.D.
Member, Board of Directors
Public-company leadership · Life sciences · Strategic growth
Dr. Ji is Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company. His disclosed experience includes senior executive and board leadership across biotechnology and life-science companies.
- SMPORTRAIT RESERVED03
Stephen Ma
Member, Board of Directors
Capital markets · Finance · Public-company operations
Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and a Director of Scilex Holding Company. His background spans finance, accounting and operating leadership.
- JYPORTRAIT RESERVED04
Jaedong Yoon
Member, Board of Directors
Institutional strategy · Governance · U.S.–Korea execution
Jaedong Yoon serves as Chief Executive Officer of JP3E Development Corp. and as a Senior Advisor to Murua Korea Corp. His disclosed experience covers governance, institutional finance and international business coordination.
Roles and biographical information reflect JP3E public announcements as of August 14, 2026. View the Board appointment announcement ↗
HOLDINGS